References
- Gomes T, Kitchen SA, Murray R. Measuring the burden of opioid-related mortality in Ontario, Canada, during the COVID-19 pandemic. JAMA Netw Open. 2021;4(5):e2112865–8. doi:10.1001/jamanetworkopen.2021.12865.
- Currie JM, Schnell MK, Schwandt H, Zhang J. Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the COVID-19 pandemic. JAMA Netw Open. 2021;4(4):e216147–e216147. doi:10.1001/jamanetworkopen.2021.6147.
- Government of Canada. Frequently asked questions: Subsection 56(1)class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic; 2020 [accessed 2021 July 29]. https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/policy-regulations/policy-documents/section-56-1-class-exemption-patients-pharmacists-practitioners-controlled-substances-covid-19-pandemic.html.
- Dhalla IA, Mamdani MM, Gomes T, Juurlink DN. Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Can Fam Physician. 2011;57(3): e92LP–e96. http://www.cfp.ca/content/57/3/e92.abstract
- Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, et al. Opioid prescriptions for chronic pain and overdose. Ann Intern Med. 2010;152(2):85–92. doi:10.7326/0003-4819-152-2-201001190-00006.
- OHDP. The Ontario Health Data Platform; 2020 [accessed 2021 Mar 15]. https://ohdp.ca/.
- Nielsen K A timeline of COVID-19 in Ontario. Global news; 2021 May 10 [accessed 2021 Dec 21]. https://globalnews.ca/news/6859636/ontario-coronavirus-timeline/.